SYNERGY PHARMACEUTICALS, INC. — Form D/A
SYNERGY PHARMACEUTICALS, INC. of New York, NY, a company, filed a Form D amendment with the SEC on 2009-11-18. The offering totals $18.2M, of which $15.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-11-18
- Form: D/A
- Accession: 0001104659-09-065735
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $18.2M
- Amount sold: $15.9M
- Remaining: $2.3M
- Investors: 45
- Date of first sale: 2009-02-12
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-84127
Issuer
- Name: SYNERGY PHARMACEUTICALS, INC.
- CIK: 001347613
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Incorporated: 2005
- Address: 420 Lexington Avenue, New York, NY, 10170
- Phone: 212-297-0020
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| thomas H adams | Director | carlsbad, CA |
| John K Brancaccio | Director | New York, NY |
| Gabriele M Cerrone | Director | New York, NY |
| Gary S Jacob | Director | New York, NY |
| Melvin K Spigelman | Director | New York, NY |
| Bernard K Denoyer | Executive Officer | New York, NY |
| Gary S Jacob | Executive Officer | New York, NY |
| Kunwar M Shailubhai | Executive Officer | New York, NY |
| John Brancaccio | Director | San Diego, CA |
| Kunwar Shailubhai | Executive Officer | New York, NY |
| Bernard Denoyer | Executive Officer | New York, NY |
Other filings by this issuer (1)
More